Genevia Technologies ltd
| Privately held company | |
| ISIN | 🆔 |
| Industry | Bioinformatics |
| Founded 📆 | 2011 |
| Founder 👔 | |
| Headquarters 🏙️ | Tampere, Finland |
Area served 🗺️ | |
Key people | Antti Ylipää (CEO), Matti Nykter (CSO), Klaus Breitholtz (Partner) |
| Members | |
Number of employees | >15 |
| 🌐 Website | https://www.geneviatechnologies.com |
| 📇 Address | |
| 📞 telephone | |
Genevia Technologies is a Finnish bioinformatics company. Genevia Technologies offers bioinformatics consulting and analysis of next-generation sequencing, proteomics, and microarray data. They operate in Scandinavia, Central Europe, and North America and have clients in both the life sciences industry and academia. Genevia's head office is located in Tampere, Finland.[1][2][3]
History
Genevia Technologies was founded in 2011 as a spin-off company from Tampere University of Technology.[4] A founder of the company, Professor Matti Nykter[5], is a bioinformatics professor at Tampere University[6] and leads a Computational Biology research group. [7]
References
- ↑ "Genevia Technologies Ltd. | Labs Explorer". www.labsexplorer.com. Retrieved 2020-11-10.
- ↑ "Business Finland - Genevia Technologies". Business Finland. Unknown parameter
|url-status=ignored (help) - ↑ "Bioinformatics company". Genevia Technologies. Retrieved 2020-11-10.
- ↑ "Genevia Technologies". thehub.io. Retrieved 2020-11-10.
- ↑ "Genevia Technologies Oy". www.finbio.net. Retrieved 2020-11-10.
- ↑ "Matti Nykter - Tampere University". Tampere University. Unknown parameter
|url-status=ignored (help) - ↑ "Computational Biology – Computational Biology group Prof. Matti Nykter". Retrieved 2020-11-10.
This article "Genevia Technologies" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Genevia Technologies. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
